<DOC>
	<DOCNO>NCT02175719</DOCNO>
	<brief_summary>Investigation clinical condition patient cervical dystonia Toronto Western Spasmodic Torticollis Scale ( TWSTRS )</brief_summary>
	<brief_title>Post-marketing Surveillance Administration Botulinum Toxin Type B ( NerBloc ) -Investigation Clinical Condition Patients With Change From Botulinum Toxin Type A</brief_title>
	<detailed_description />
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Torticollis</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Inclusion criterion : Patients cervical dystonia treat botulinum toxin type A past . Patients enrol NB01S evaluate TWSTRS first injection NerBloc .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Torticollis</keyword>
	<keyword>rimabotulinumtoxinB</keyword>
</DOC>